Option Care Health, Inc. $OPCH Shares Purchased by Axiom Investors LLC DE

Key Points

• Axiom Investors LLC DE increased its stake in Option Care Health, Inc. by 111.2%, acquiring an additional 190,417 shares, and now holds approximately 0.22% of the company worth $12.64 million.
• Several brokerages have upgraded their ratings on Option Care Health, with UBS upgrading to "buy" and raising the price target from $38.00 to $40.00, reflecting strong analyst support for the stock.
• Option Care Health's recent quarterly earnings surpassed expectations, reporting an EPS of $0.41 and revenue of $1.42 billion, marking a 15.4% year-over-year increase.

Axiom Investors LLC DE lifted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 111.2% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 361,615 shares of the company's stock after buying an additional 190,417 shares during the period. Axiom Investors LLC DE owned 0.22% of Option Care Health worth $12,638,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Public Employees Retirement System of Ohio grew its stake in Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after buying an additional 332 shares during the period. US Bancorp DE lifted its holdings in shares of Option Care Health by 5.0% during the 1st quarter. US Bancorp DE now owns 8,199 shares of the company's stock valued at $287,000 after acquiring an additional 393 shares in the last quarter. State of Michigan Retirement System lifted its holdings in shares of Option Care Health by 1.2% during the 1st quarter. State of Michigan Retirement System now owns 40,759 shares of the company's stock valued at $1,425,000 after acquiring an additional 500 shares in the last quarter. Louisiana State Employees Retirement System lifted its position in Option Care Health by 1.1% during the 1st quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company's stock worth $1,667,000 after acquiring an additional 500 shares in the last quarter. Finally, State of Alaska Department of Revenue boosted its holdings in Option Care Health by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock worth $696,000 after acquiring an additional 525 shares during the period. Hedge funds and other institutional investors own 98.05% of the company's stock.

Analysts Set New Price Targets

OPCH has been the subject of several analyst reports. Citigroup restated an "outperform" rating on shares of Option Care Health in a research note on Thursday, July 31st. JMP Securities raised their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research note on Thursday, July 31st. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and a consensus target price of $35.75.

Option Care Health Stock Up 0.6%

Option Care Health stock traded up $0.16 during midday trading on Thursday, hitting $28.75. The stock had a trading volume of 1,777,606 shares, compared to its average volume of 1,861,275. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The business has a fifty day moving average price of $29.71 and a 200 day moving average price of $31.69. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The stock has a market cap of $4.67 billion, a P/E ratio of 23.00, a P/E/G ratio of 1.70 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same period in the previous year, the business earned $0.30 EPS. The business's quarterly revenue was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insiders Place Their Bets

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the company's stock in a transaction dated Wednesday, August 20th. The shares were acquired at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the transaction, the director owned 375,390 shares of the company's stock, valued at $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Timothy P. Sullivan bought 20,000 shares of the business's stock in a transaction on Thursday, August 21st. The stock was bought at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the purchase, the director directly owned 49,229 shares of the company's stock, valued at $1,354,289.79. The trade was a 68.43% increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is currently owned by corporate insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.